S-Adenosylmethionine enhances the inhibitory effect of gemcitabine against pancreatic cancer cells via suppression of the EGFR/AKT pathways

Aran V, Omerovic J (2019) Current approaches in NSCLC targeting K-RAS and EGFR. Int J Mol Sci 20:5701 Awad MG et al (2020) Graviola leaves extract enhances the anticancer effect of cisplatin on various cancer cell lines. Mol Cell Toxicol 6:385–399 Barreto SG, D’Onise K (2020) Pancreatic cancer in the Australian population: identifying opportunities for intervention. ANZ J Surg 90:2219–2226 Bray F et al (2018) Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424 Burris HA 3rd et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403–2413 Chou TC (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70:440–446 Hackeng WM, Hruban RH, Offerhaus GJ, Brosens LA (2016) Surgical and molecular pathology of pancreatic neoplasms. Diagn Pathol 11:47 He S et al (2020) Triptolide inhibits PDGF-induced proliferation of ASMCs through G0/G1 cell cycle arrest and suppression of the AKT/NF-κB/cyclinD1 signaling pathway. Eur J Pharmacol 867:172811 Ho WJ, Jaffee EM, Zheng L (2020) The tumour microenvironment in pancreatic cancer—clinical challenges and opportunities. Nat Rev Clin Oncol 17:527–540 Jain T, Dudeja V (2021) The war against pancreatic cancer in 2020—advances on all fronts. Nat Rev Gastroenterol Hepatol 18:99–100 Li TW et al (2009) S-adenosylmethionine and methylthioadenosine inhibit cellular FLICE inhibitory protein expression and induce apoptosis in colon cancer cells. Mol Pharmacol 76:192–200 Li Q et al (2017) S-adenosylmethionine attenuates oxidative stress and neuroinflammation induced by amyloid-β through modulation of glutathione metabolism. J Alzheimers Dis 58:549–558 Li Y, Pan J, Gou M (2019) The anti proliferation, cycle arrest and apoptotic inducing activity of peperomin E on prostate cancer PC-3 cell line. Molecules 24:1472 Liu T et al (2018) Mechanisms of MAFG dysregulation in cholestatic liver injury and development of liver cancer. Gastroenterology 155:557–571 Lozano-Rosas MG et al (2020) Diminished S-adenosylmethionine biosynthesis and its metabolism in a model of hepatocellular carcinoma is recuperated by an adenosine derivative. Cancer Biol Ther 21:81–94 Mahmood N et al (2017) Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis in vivo; therapeutic and chemopreventive applications. Oncotarget 9:5169–5183 Mahmood N et al (2020) S-adenosylmethionine in combination with decitabine shows enhanced anti-cancer effects in repressing breast cancer growth and metastasis. J Cell Mol Med 24:10322–10337 Mitsudomi T, Yatabe Y (2010) Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS J 277:301–308 N’Guessan KF et al (2020) Enhanced efficacy of combination of gemcitabine and phosphatidylserine-targeted nanovesicles against pancreatic cancer. Mol Ther 28:1876–1886 Oettle H et al (2013) Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA 310:1473–1481 Parashar S et al (2015) S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications. Cancer Med 4:732–744 Pavliukeviciene B et al (2019) Amyloid β oligomers inhibit growth of human cancer cells. PLoS ONE 14:e0221563 Ren D et al (2020) Metformin activates the STING/IRF3/IFN-β pathway by inhibiting AKT phosphorylation in pancreatic cancer. Am J Cancer Res 10:2851–2864 Saccarello A et al (2020) Oral administration of S-adenosylmethionine (SAMe) and lactobacillus plantarum HEAL9 improves the mild-to-moderate symptoms of depression: a randomized, double-blind, placebo-controlled study. Prim Care Companion CNS Disord 22:19m02578 Takenaka T et al (2019) Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells. Int J Pharm 572:118762 Tang R et al (2020) The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer. Ann Transl Med 8:1347 Tempero MA (2019) NCCN guidelines updates: pancreatic cancer. J Natl Compr Canc Netw 17:603–605 Tewari D et al (2019) Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy. Semin Cancer Biol S. https://doi.org/10.1016/j.semcancer.2019.12.008 Tian J et al (2020) N6-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression. Gut 69:2180–2192 Tompkins KD, Thorburn A (2019) Regulation of apoptosis by autophagy to enhance cancer therapy. Yale J Biol Med 92:707–718 Torphy RJ, Fujiwara Y, Schulick RD (2020) Pancreatic cancer treatment: better, but a long way to go. Surg Today 50:1117–1125 Yan L et al (2019a) S-adenosylmethionine affects cell cycle pathways and suppresses proliferation in liver cells. J Cancer 10:4368–4379 Yan X et al (2019b) MicroRNA-21-5p are involved in apoptosis and invasion of fibroblast-like synoviocytes through PTEN/PI3K/AKT signal. Cytotechnology 71:317–328 Zhang S, Wang J, Yao T, Tao M (2020) LncRNA ZFAS1/miR-589 regulates the PTEN/PI3K/AKT signal pathway in the proliferation, invasion and migration of breast cancer cells. Cytotechnology 72:415–425 Zhao et al (2010) Inhibitory effect of S-adenosylmethionine on the growth of human gastric cancer cells in vivo and in vitro. Chin J Cancer 9:752–760 Zhou X et al (2019) TRIM44 is indispensable for glioma cell proliferation and cell cycle progression through AKT/p21/p27 signaling pathway. J Neurooncol 145:211–222